Addressing the Risks That Trade Secret Protections Pose for Health and Rights.

Allison Durkin, Amparita Sta. Maria, Brandon Willmore, Amy Kapczynski

PubMed · 2021 · 19 citations · 6 references

Full text

Open access

Concepts

TL;DR

Human rights frameworks grant the right to health and benefit from scientific progress, obligating states to ensure access to medicines, yet while patent impacts are well studied, trade secrecy law’s effect on access has received little attention. The paper examines how trade secrecy protection conflicts with medicine access by blocking clinical trial data, hindering pandemic manufacturing scale‑up, and discouraging whistleblowing. The authors illustrate this conflict by detailing how trade secrecy prevents researchers from accessing clinical trial data, undermines pandemic manufacturing expansion, and deters whistleblowers. They propose internationally compliant measures to reduce the trade secrecy–health conflict and advance health without compromising innovation.

Abstract

Human rights frameworks afford everyone the right to health and the right to enjoy the benefits of scientific progress and its applications. Both come together to create state obligations to ensure access to medicines and other health technologies. Though the impact of patents on access to high-quality, affordable medicines and health technologies has been well described, there has been little attention to the impact of trade secrecy law in this context. In this paper, we describe how trade secrecy protection comes into conflict with access to medicines-for example, by preventing researchers from accessing clinical trial data, undermining the scale-up of manufacturing in pandemics, and deterring whistleblowers from reporting industry misconduct. The paper proposes measures to diminish the conflict between trade secrecy and health that are consistent with international law and will advance health without undermining innovation.

References

6